SCHEMBL29495264

SCHEMBL29495264

O=[N+]([O-])c1cnc(OCCN2CCOCC2)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
SMN1; SMN2 Q16637 4/20 0.48
KMT2A Q03164 2/20 0.48
KDM4E B2RXH2 2/20 0.47
MAPT P10636 5/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
POLB P06746 2/20 0.46
MEN1 O00255 1/20 0.46
TSHR P16473 1/20 0.46
NPC1 O15118 2/20 0.44
SIGMAR1 Q99720 2/20 0.44
RAB9A P51151 1/20 0.44
LMNA P02545 1/20 0.43
KCNJ1 P48048 1/20 0.43
CYP1A2 P05177 1/20 0.43
PKM P14618 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28722474 1.00 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2KMT2AKDM4EMAPT
SCHEMBL14397720 0.86 KMT2A (0.54) ALDH1A1SMN1; SMN2KMT2AKDM4EMAPT
SCHEMBL4659282 0.86 SMN1; SMN2 (0.48) ALDH1A1SMN1; SMN2KMT2AKDM4EMAPT
SCHEMBL7300773 0.81 TSHR (0.57) ALDH1A1KDM4EMAPTTSHRNPC1
SCHEMBL4791655 0.79 HTR2A (0.48) ALDH1A1SMN1; SMN2KMT2AKDM4EMAPT
SCHEMBL22936210 0.79 ALDH1A1 (0.52) ALDH1A1KMT2AKDM4EMAPTMEN1
SCHEMBL29739524 0.78 POLB (0.54) ALDH1A1SMN1; SMN2KMT2AKDM4EMAPT
SCHEMBL29177207 0.78 POLB (0.54) ALDH1A1SMN1; SMN2KMT2AKDM4EMAPT
SCHEMBL29277214 0.77 TSHR (0.67) ALDH1A1SMN1; SMN2KMT2AKDM4EMAPT
SCHEMBL4768514 0.77 HTR2A (0.49) ALDH1A1SMN1; SMN2KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119431323-A Heterobicyclic amides as CD38 inhibitors 贝林格尔·英格海姆国际有限公司 2025-02-14 CN disclosed
CN-114423753-B Heterobicyclic amides as CD38 inhibitors 里邦医疗公司 2024-09-17 CN disclosed
CN-114423753-A Heterobicyclic amides as CD38 inhibitors 里邦医疗公司 2022-04-29 CN disclosed